Abstract:Biologicals including monoclonal antibodies are the current flagships in pharmaceutical industry. However, they are exposed to a multitude of destabilization conditions like for instance hydrophobic interfaces, leading to reduced biological activity. Polysorbates are commonly applied to effectively stabilize these active pharmaceutical ingredients against colloidal stress. Nevertheless, chemical instability of polysorbate via hydrolysis or oxidation results in degradation products that might form particles via phase separation. Polysorbates are mixtures of hundreds of individual components, and recently purer quality grades with reduced variations in the fatty acid composition are available. As the protective function of polysorbate itself is not completely understood, even less is known about its individual components, raising the question of the existence of a superior polysorbate species in respect to protein stabilization or degradation susceptibility. Here, we evaluated the protective function of four main fractions of polysorbate 20 (PS20) in agitation studies with monoclonal antibodies, followed by particle analysis as well as protein and polysorbate content determination. The commercially-available inherent mixtures PS20 high purity and PS20 all-laurate, as well as the fraction isosorbide-POE-monolaurate showed superior protection against mechanical–induced stress (visual inspection and turbidity) at the air–water interface in comparison to sole sorbitan-POE-monolaurate, -dilaurate, and -trilaurate. Fractions composed mainly of higher–order esters like sorbitan-POE-dilaurate and sorbitan-POE-trilaurate indicated high turbidities as indication for subvisible and small particles accompanied by a reduced protein monomer content after agitation. For the isosorbide-POE-monolaurates as well as for the inherent polysorbate mixtures no obvious differences in protein content and protein aggregation (SEC) were observed, reflecting the observations from visual appearance. However, absolute polysorbate concentrations vary drastically between different species in the actual formulations. As there are still open questions in respect to protein specificity or regarding mixtures versus individual components of PS20, further studies must be performed, to gain a better understanding of a "generalized" stabilizing effect of polysorbates on monoclonal antibodies. The knowledge of the characteristics of individual polysorbate species can have the potential to pave the way to superior detergents in respect to protein stabilization and/or degradation susceptibility.

The Characterization of Polysorbate

Extensive Characterization of Polysorbate 80 Oxidative Degradation Under Stainless Steel Conditions

The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation

How enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability

Detailed profiling of polysorbate 80 oxidative degradation products and hydrolysates using liquid chromatography–tandem mass spectrometry analysis

Prediction of long-term polysorbate degradation according to short-term degradation kinetics

Discrimination of Polysorbate 20 by High-Performance Liquid Chromatography-Charged Aerosol Detection and Characterization for Components by Expanding Compound Database and Library

Novel Strategy to Rapidly Profile and Identify Oxidized Species of Polysorbate 80 Using Ultra-High-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry

A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation

Existence of a superior polysorbate fraction in respect to protein stabilization and particle formation?

Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the Future

Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins

Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers

Monitoring Polysorbate 80 Degradation in Protein Solutions Using Total Holographic Characterization

Comprehensive investigation of factors influencing the degradation of polysorbate 20: Insights into mechanisms and interactions using a design of experiments approach

Comparative analysis and mechanistic insights into polysorbate 80 stability differences in biopharmaceutical buffer systems

A Fast Strategy for Profiling and Identifying Pharmaceutic Excipient Polysorbates by Ultra-High Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry.

Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method

Surface Tension and Self-association Properties of Aqueous Polysorbate 20 HP and 80 HP Solutions: Insights into Protein Stabilisation Mechanisms

Coarse-Grained Molecular Dynamics Simulation of Heterogeneous Polysorbate 80 Surfactants and their Interactions with Small Molecules and Proteins

Polysorbate stability: Effects of packaging materials, buffers, counterions, and pH